Alzheimer or Dementia: What’s the Difference? Complete Guide to Understanding
The terms “Alzheimer” and “dementia” are often used as synonyms. However, they do not refer to exactly the same thing. Here’s everything you need to know.
“He has Alzheimer's disease.” “She is developing dementia.” These two phrases are often heard as equivalent, in families, in the media, sometimes even in the hallways of care facilities. Yet, confusion persists: Alzheimer and dementia are not the same thing, even though Alzheimer's disease is by far the most common form of dementia. Understanding this difference is not a simple semantic exercise: it is a condition for obtaining the correct diagnosis, accessing the right care, and better supporting a loved one. This guide clearly explains the relationship between these two concepts, the different forms of dementia, the biological mechanisms involved, and what this concretely implies for patients and families.
Dementia: a Generic Term, Not a Diagnosis
The first thing to understand is that dementia is not a disease in itself, but a syndrome — that is, a set of symptoms that can have multiple causes. The official medical term, preferred today in the scientific literature, is major neurocognitive disorder (according to the DSM-5, the Diagnostic and Statistical Manual of Mental Disorders). But the word “dementia” remains widely used in clinical practice and among the general public.
For a dementia syndrome to be diagnosed, three conditions must be met: significant cognitive decline compared to the previous level, in at least one area (memory, language, attention, praxis, executive functions, perception); this decline must be severe enough to interfere with daily activities and autonomy; and it must not be better explained by another disorder (depression, delirium, medication effect).
“Dementia is a clinical syndrome. Alzheimer's disease is a specific neuropathological disease. One is a container, the other is a content among others.”
Cognitive Domains Affected in Dementia
Dementia can affect different cognitive functions depending on the underlying cause and the affected brain regions. The main areas involved are: memory (especially episodic memory — memories of lived events); language (finding words, understanding, naming objects); executive functions (planning, organizing, solving problems); praxis (coordinating complex gestures); visuospatial functions (navigating in space); and social cognition (recognizing emotions, understanding social situations).
Alzheimer's Disease: The Most Common Cause of Dementia
Alzheimer's disease is a specific neurodegenerative disease, characterized by precise and progressive brain lesions. It accounts for between 60 and 70% of all dementia cases, which explains the frequent confusion between the two terms. But while every Alzheimer's disease leads to dementia (in the advanced stage), not every dementia is Alzheimer's disease.
Characteristic Lesions of Alzheimer's
Neuropathologically, Alzheimer's disease is defined by two types of characteristic lesions, highlighted by Alois Alzheimer himself in 1906:
The Two Biological Markers of Alzheimer's Disease
Amyloid plaques (or senile plaques): extracellular deposits of beta-amyloid protein fragments that accumulate in the spaces between neurons. They disrupt synaptic communication and induce a local inflammatory response. These plaques appear many years — sometimes decades — before the first clinical symptoms.
Neurofibrillary tangles: intracellular accumulations of abnormally phosphorylated tau protein that form twisted filaments inside neurons. They disrupt the transport of nutrients and signals within the neuron, leading to its progressive death.
These two types of lesions spread according to a relatively predictable anatomical pattern — described by Braak stages — starting with the hippocampus and entorhinal regions (hence the early impairment of episodic memory), and then gradually extending throughout the cortex.
The Progression of Alzheimer's Disease
Alzheimer's disease typically progresses through several phases. A silent preclinical phase, which can last 15 to 20 years, during which lesions accumulate without causing noticeable symptoms. A prodromal phase (or MCI — Mild Cognitive Impairment — amnesic), characterized by noticeable episodic memory disturbances but without significant impact on autonomy. Then the phase of established dementia, mild, moderate, and then severe, with an increasing impact on daily activities and autonomy.
It is important to emphasize that recent research has shown that the first biological changes of Alzheimer's disease can be detected in the cerebrospinal fluid or by PET imaging (positron emission tomography) years before any symptoms — opening up possibilities for early preventive intervention.
Other Forms of Dementia: Beyond Alzheimer's
Alzheimer's disease is the most well-known, but other pathologies can cause a dementia syndrome, with different cognitive profiles, progressions, and management. Knowing them allows for a better understanding of diagnoses and adapting support.
Vascular Dementia (15-20% of cases)
Vascular dementia is caused by brain lesions of vascular origin: cerebral infarctions (Stroke), multiple micro-infarctions (leukoaraiosis), or chronic cerebral perfusion disorders. Unlike Alzheimer's disease, its progression is often stepwise — worsening in stages after each new vascular episode — rather than progressive and continuous. Executive functions and processing speed are often more affected than episodic memory in the early stages. Vascular risk factors (hypertension, diabetes, atrial fibrillation) are the main preventive levers.
Lewy Body Dementia (10-15% of cases)
Lewy body dementia is characterized by abnormal deposits of alpha-synuclein protein (the “Lewy bodies”) in neurons. It presents a distinct clinical profile: significant fluctuations in cognitive performance (sometimes from one day to the next), early and recurrent visual hallucinations, parkinsonian syndrome (slowness, rigidity, balance disorders), and particular sensitivity to certain neuroleptics — which can be dangerous for these patients. Dementia associated with Parkinson's disease shares similar mechanisms.
Frontotemporal Dementia (5-10% of cases)
Frontotemporal dementia (FTD) is a degeneration of the frontal and temporal lobes of the brain. It typically affects younger people (between 45 and 65 years old) than other dementias. Its profile is characteristic: changes in personality and behavior (disinhibition, apathy, socially inappropriate behaviors) or language disorders (primary progressive aphasia) dominate the clinical picture, while episodic memory is preserved for a long time. This atypical profile can delay diagnosis.
| Type of Dementia | Frequency | Dominant Early Symptoms | Progression |
|---|---|---|---|
| Alzheimer's Disease | 60-70% | Episodic memory (recent forgetfulness) | Progressive and continuous |
| Vascular Dementia | 15-20% | Executive functions, slowness | Stepwise (Stroke) |
| Lewy Body | 10-15% | Hallucinations, fluctuations, parkinsonism | Progressive with fluctuations |
| Frontotemporal | 5-10% | Behavior, personality, language | Progressive (faster) |
| Mixed Forms | 10-20% | Variable depending on components | Progressive |
Mixed Forms and Reversible Dementias
It is common, especially among very elderly people, to find mixed forms combining Alzheimer's lesions and vascular lesions. These mixed forms represent a significant proportion of dementias in old age. Furthermore, some causes of cognitive syndrome are potentially reversible: hypothyroidism, vitamin B12 deficiency, severe depression (depressive pseudo-dementia), normal pressure hydrocephalus, iatrogenic effects of certain medications. This is why a complete biological and clinical assessment is essential before any diagnosis of neurodegenerative dementia — to avoid missing a treatable cause.
⚠️ Do not confuse with normal aging
Forgetting where you put your keys is common at any age. What distinguishes normal aging from dementia is the severity, progression, and impact on daily life. In normal cognitive aging, it may take longer to find a word or information, but you eventually succeed. In dementia, forgetfulness progressively worsens and genuinely interferes with usual activities. A persistent doubt deserves a professional evaluation.
How Do We Distinguish Between Different Dementias?
The differential diagnosis of dementias — that is, distinguishing which form of dementia is involved — is one of the most complex tasks in neurology and geriatrics. It relies on several complementary steps.
The Diagnostic Assessment
The diagnostic evaluation of dementia typically includes: a thorough clinical interview (history, symptom history, medical and family history); a neuropsychological assessment that objectively characterizes the profile of cognitive impairments (memory, language, attention, executive functions, praxis); a biological assessment (to eliminate treatable causes); a brain imaging (primarily MRI, sometimes PET scan) allowing visualization of regional atrophies, vascular lesions, or amyloid deposits; and sometimes an analysis of cerebrospinal fluid (Alzheimer biomarkers: beta-amyloid, tau, phospho-tau) or genetic tests in familial forms.
🚦 DYNSEO Alert Signals Map
The Alert Signals Map DYNSEO is a practical tool designed to help families and professionals quickly identify cognitive behaviors and difficulties that warrant a medical evaluation. It allows for structuring the observation of symptoms without alarmism, so as not to miss a valuable intervention window. To be consulted before any medical appointment.
The role of neuropsychological assessment
The neuropsychological assessment is central to the diagnosis of dementias. It not only confirms the existence of cognitive decline and measures its severity but also characterizes the profile of the impairments — which significantly guides the etiological diagnosis. An early and predominant impairment of episodic memory (with forgetfulness over time) is characteristic of Alzheimer's disease. Predominant executive and attentional disorders point towards vascular dementia. Behavioral and language disorders with relatively preserved memory suggest frontotemporal dementia.
Alzheimer's disease and dementia: key differences to remember
Let's summarize the essential distinctions between Alzheimer's and dementia for a clear understanding:
The relationship between dementia and Alzheimer's disease in 5 points
1. Dementia is a syndrome, Alzheimer's is a disease. Dementia refers to a set of severe cognitive symptoms; Alzheimer's is one of the diseases that can cause this syndrome.
2. Alzheimer's is the most common cause of dementia (60-70%), but not the only one. Vascular dementias, Lewy body dementia, frontotemporal dementias, and mixed cases represent the other instances.
3. Not every Alzheimer's disease necessarily leads to dementia from the start. There are preclinical and prodromal phases (MCI) before the stage of actual dementia.
4. Accurate etiological diagnosis is crucial. It conditions the management, available treatments (some effective medications for Alzheimer's are contraindicated in Lewy body dementia), and the prognosis.
5. Confusion between the two terms can delay diagnosis. Atypical symptoms (behavioral, language, early motor) should lead to other etiologies than just Alzheimer's disease.
Alzheimer's disease in detail: symptoms, stages, and evolution
Since Alzheimer's disease represents the majority of dementia cases, it is useful to describe its clinical picture and typical evolution more precisely.
The stages of Alzheimer's disease
Alzheimer's disease classically progresses in three main stages, with duration varying significantly from person to person (on average 8 to 10 years between diagnosis and death, but with significant variations from 3 to 20 years).
Mild stage (beginning of the disease)
Forgetfulness mainly concerns recent events: conversations from the previous day, appointments, names of recently met people. The person may get lost in unfamiliar places. They may have difficulty finding words (tip-of-the-tongue phenomenon). They remain autonomous for most daily activities but may need help with complex tasks (financial management, planning). They are often aware of their difficulties, which can lead to anxiety and reactive depression.
Moderate stage
Forgetfulness extends to older events. Difficulties with temporal-spatial orientation appear (not knowing the date, getting lost in familiar places). Language simplifies. Behavioral disorders may appear: agitation, wandering, sleep disturbances, sometimes hallucinations. Dependence for daily activities increases (dressing, hygiene, meals). The burden on the primary caregiver becomes significant.
Severe stage
Verbal communication becomes very limited. Recognition of loved ones may be lost. The person becomes totally dependent for all care. Physical complications arise (swallowing disorders, infections, immobilization). Psychological and emotional life remains present even at this advanced stage: touch, music, familiar voices, and positive emotions can still be felt and communicated.
Support and cognitive stimulation: adapting to the cause
A precise understanding of the etiological diagnosis is not only academic: it has direct implications for support and cognitive stimulation.
Cognitive stimulation in Alzheimer's disease
In Alzheimer's disease, cognitive stimulation is one of the best-documented non-pharmacological interventions to maintain functional abilities and quality of life. It leverages long-preserved memories (implicit memory, procedural memory, emotional memory) to maintain engagement, pleasure, and self-esteem. The most effective activities are those that are individualized, regular, adapted to the current cognitive level, and that preserve a sense of competence.
🧩 SCARLETT — Designed for people with Alzheimer's and their caregivers
SCARLETT is a cognitive stimulation application developed by DYNSEO specifically for seniors, people with Alzheimer's or Parkinson's, and their caregivers. Its simplified interface (large icons, intuitive navigation, no ads), its progressive exercises in 5 levels of difficulty, and its catalog of over 30 activities covering all cognitive domains make it a suitable tool for all mild and moderate phases of the disease. Used in facilities or at home, SCARLETT transforms stimulation sessions into moments of shared enjoyment.
Discover SCARLETTMonitoring sessions and coordinating care
When multiple professionals (speech therapist, psychomotrician, occupational therapist, nursing assistant) and family members intervene with the same person, coordination and monitoring of stimulation activities are essential to ensure coherence and adjust approaches. The DYNSEO Session Monitoring Sheet allows for documenting stimulation sessions, observing the evolution of abilities, and facilitating communication between different stakeholders.
What families need to know
For the relatives of a person with dementia, understanding the diagnosis is often a painful but necessary step. Several points are essential to assimilate.
The person remains a person
Even with severe dementia, the identity, emotions, tastes, and dignity of the person persist. Non-verbal communication remains possible.
Predictability helps
Stable routines, familiar environments, and clear temporal markers reduce anxiety and behavioral disorders.
The caregiver needs support
The caregiver's exhaustion is real. Respite time, psychological support, and support groups are essential.
Early diagnosis changes everything
The earlier the diagnosis is made, the sooner measures can be implemented to maintain quality of life and plan for the future.
When to consult? The importance of early diagnosis
Early diagnosis of dementia — ideally at the MCI stage (mild cognitive impairment) — represents a valuable intervention window. It allows for implementing cognitive stimulation strategies and medical management at the time when they are most effective, anticipating important decisions (advance directives, organizing home care, legal and financial aspects), and accessing clinical trials for emerging treatments.
Validated cognitive tests often constitute the first step. DYNSEO offers a free online memory test and a free mental age test that can help objectify initial concerns and motivate a medical consultation. These tools do not replace a professional neuropsychological assessment but provide a useful first reference.
🎓 DYNSEO Specialized Training on Dementia
Healthcare professionals and those in the medico-social field supporting people with dementia can benefit from DYNSEO training on neurodegenerative disorders and Alzheimer's disease. These Qualiopi certified trainings provide keys to understanding pathological mechanisms, improving stimulation and support practices, and better supporting families in this difficult journey.
Conclusion: two words, a fundamental relationship to understand
The distinction between dementia and Alzheimer's disease is not a subtlety reserved for neurologists. It is an essential key to understanding for families, caregivers, healthcare professionals, and the individuals themselves. Alzheimer's is the most common cause of dementia — but dementia is a syndrome with multiple faces, whose precise cause guides diagnosis, treatment, and support.
When faced with cognitive concerns about oneself or a loved one, the first step is not to remain in doubt. A professional assessment allows for distinguishing normal aging, mild cognitive disorders, and confirmed dementia, identifying the cause, and acting at the right time. Resources exist — medical, cognitive, digital, human — to accompany this journey with the best possible quality of life.
To start, explore our online cognitive tests, consult our Alert Signal Map, and discover how the SCARLETT app can support people with dementia and their caregivers on a daily basis.